EMEA-002942-PIP02-20-M01
Submitted by Anonymous (not verified) on 4 July 2024 - 13:56
EMEA-002942-PIP02-20-M01
EMEA-002935-PIP01-20-M03
Submitted by Anonymous (not verified) on 4 July 2024 - 13:52
EMEA-002935-PIP01-20-M03
EMEA-002443-PIP01-18-M02
Submitted by Anonymous (not verified) on 4 July 2024 - 13:47
EMEA-002443-PIP01-18-M02
EMEA-002705-PIP01-19-M01
Submitted by Anonymous (not verified) on 4 July 2024 - 13:43
EMEA-002705-PIP01-19-M01
EMEA-002597-PIP05-21-M01
Submitted by Anonymous (not verified) on 4 July 2024 - 13:36
EMEA-002597-PIP05-21-M01
Recent additions to EMA’s management team
Submitted by Anonymous (not verified) on 4 July 2024 - 11:25
Recent additions to EMA’s management team
Appendix 1: Acceptable intakes established for N-nitrosamines
Submitted by Anonymous (not verified) on 4 July 2024 - 9:49
Appendix 1: Acceptable intakes established for N-nitrosamines
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka, emtricitabine,tenofovir disoproxil, Date of authorisation: 09/12/2016, Revision: 14, Status: Authorised
Submitted by Anonymous (not verified) on 4 July 2024 - 8:48
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Krka, emtricitabine,tenofovir disoproxil, Date of authorisation: 09/12/2016, Revision: 14, Status: Authorised
List of European Union reference dates and frequency of submission of periodic safety update reports (PSURs)
Submitted by Anonymous (not verified) on 3 July 2024 - 13:57
List of European Union reference dates and frequency of submission of periodic safety update reports (PSURs)
Clinical Trial Information System (CTIS) - Sponsor handbook
Submitted by Anonymous (not verified) on 3 July 2024 - 11:11
Clinical Trial Information System (CTIS) - Sponsor handbook